JP5602027B2 - 未来の性質を予測する方法 - Google Patents
未来の性質を予測する方法 Download PDFInfo
- Publication number
- JP5602027B2 JP5602027B2 JP2010546371A JP2010546371A JP5602027B2 JP 5602027 B2 JP5602027 B2 JP 5602027B2 JP 2010546371 A JP2010546371 A JP 2010546371A JP 2010546371 A JP2010546371 A JP 2010546371A JP 5602027 B2 JP5602027 B2 JP 5602027B2
- Authority
- JP
- Japan
- Prior art keywords
- future
- properties
- measured
- property
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 claims description 62
- 238000005259 measurement Methods 0.000 claims description 36
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 238000002835 absorbance Methods 0.000 claims description 13
- 239000003446 ligand Substances 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 230000028993 immune response Effects 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 230000000704 physical effect Effects 0.000 claims description 4
- 239000012491 analyte Substances 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 239000004816 latex Substances 0.000 claims description 3
- 229920000126 latex Polymers 0.000 claims description 3
- 238000000149 argon plasma sintering Methods 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 238000004020 luminiscence type Methods 0.000 claims description 2
- 239000006249 magnetic particle Substances 0.000 claims description 2
- 230000005389 magnetism Effects 0.000 claims description 2
- 239000013598 vector Substances 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- 238000004590 computer program Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Computing Systems (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Description
複数の時点で該系の複数の性質を測定し、ある期間にわたってそれぞれの性質に対して複数の測定値を生み出すこと、および
各時点で測定された各性質に関して所定加重値(predetermined weights)を用いて性質を結合し、該複数の測定された性質の結合を生み出すことにより該未来の性質を予測すること
を含む方法が提供される。
y=y(t)=r(t)+z(t)
を作り出す。差、
が予測誤差のベクトルである。LMS法により、可能な限り小さな予測誤差のベクトル
のL2ノルムを与える加重ベクトルwを生成することが可能となる。これは、wに関する二次形式‖Sw−x‖2を最小化することを意味する。
w=Q-1b (1)
であり、Q-1は行列Qの逆数である。
式中、Eは単位行列である。
Claims (17)
- プロセスを受けて反応中の1つ以上の試薬を含む系の未来の時点における未来の性質の値を予測する方法であって、
該未来の時点よりも早い複数の測定時点で該系の複数の性質を測定し、ある期間にわたってそれぞれの性質に対して複数の測定値を生み出すこと、
前記反応中の前記1つ以上の試薬の前記系の未来の性質の測定値により構成される母集団を前記複数の測定時点での前記未来の性質の既知の値および前記母集団を構成する前記未来の性質の測定値を用いて分析することにより、所定加重値を計算すること、および
各測定時点で測定された各性質に関して前記所定加重値を用いて性質を結合し、該複数の測定された性質の結合を生み出すことにより該未来の性質の値を予測すること
を含み、
前記性質が、1つ以上の既定の波長での吸光度、反射率、光散乱、蛍光発光、放射活性、発光、リン光、磁性、温度、電気伝導度および電気抵抗から選ばれる物理的性質であり、
前記予測する工程が、それぞれのスカラー積を生み出すために前記所定加重値を掛けられた各測定時点における前記複数の測定された性質を合計し、その後該スカラー積を合計することを含む方法。 - 前記複数の測定された性質の結合が、当該複数の測定された性質の線形結合である請求項1記載の方法。
- 前記所定加重値が、前記未来の性質の前記既知の値と該所定加重値を用いて予測される未来の性質の値との差異を最小化することにより計算される請求項1記載の方法。
- 前記所定加重値が最小平均二乗法を適用することにより計算される請求項3記載の方法。
- 前記測定された性質のそれぞれが、各測定時点で複数の測定値を生じさせるために同一の前記複数の測定時点で測定される請求項1〜4のいずれかに記載の方法。
- 前記系の前記測定された性質の1つが予測されるべき未来の性質である請求項1〜5のいずれかに記載の方法。
- 前記方法が被検体および結合物質を含む系の未来の性質を予測する請求項1〜6のいずれかに記載の方法。
- 前記方法が、前記プロセスが完了する際の前記系の未来の性質を予測する請求項1〜7のいずれかに記載の方法。
- さらに前記未来の性質の予測された値から前記試薬間のプロセスのプロダクトの量を決定することを含む請求項1〜8のいずれかに記載の方法。
- 前記反応が免疫反応を含む請求項1〜9のいずれかに記載の方法。
- 前記免疫反応が固体支持体を含む請求項10記載の方法。
- 前記免疫反応がリガンドおよび抗リガンド間の反応を含む請求項10記載の方法。
- 前記リガンドおよび抗リガンドが抗体および抗原を含む請求項12記載の方法。
- 前記リガンドまたは抗リガンドのいずれかが固体支持体に結合される請求項12または13記載の方法。
- 前記固体支持体が粒子を含む請求項11記載の方法。
- 前記粒子がラテックス、金ゾル、磁性粒子または蛍光粒子を含む請求項15記載の方法。
- 前記方法が、比濁またはネフェロアッセイにおいて生じる免疫反応を含むプロセスの未来の性質を予測する請求項1〜16のいずれかに記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2870708P | 2008-02-14 | 2008-02-14 | |
US61/028,707 | 2008-02-14 | ||
PCT/FI2009/000025 WO2009101242A1 (en) | 2008-02-14 | 2009-02-13 | Method for predicting a future property |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011512593A JP2011512593A (ja) | 2011-04-21 |
JP2011512593A5 JP2011512593A5 (ja) | 2012-03-29 |
JP5602027B2 true JP5602027B2 (ja) | 2014-10-08 |
Family
ID=40679582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010546371A Active JP5602027B2 (ja) | 2008-02-14 | 2009-02-13 | 未来の性質を予測する方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8548935B2 (ja) |
EP (1) | EP2245442A1 (ja) |
JP (1) | JP5602027B2 (ja) |
CN (1) | CN101946169B (ja) |
AU (1) | AU2009213995B2 (ja) |
CA (1) | CA2715241C (ja) |
RU (1) | RU2503948C2 (ja) |
WO (1) | WO2009101242A1 (ja) |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5236666A (en) * | 1989-12-01 | 1993-08-17 | Akzo N.V. | Temperature regulation in a sample handling system for an optical monitoring system |
US5646046A (en) * | 1989-12-01 | 1997-07-08 | Akzo Nobel N.V. | Method and instrument for automatically performing analysis relating to thrombosis and hemostasis |
US5708591A (en) * | 1995-02-14 | 1998-01-13 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
US6898532B1 (en) * | 1995-06-07 | 2005-05-24 | Biomerieux, Inc. | Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample |
US6429017B1 (en) * | 1999-02-04 | 2002-08-06 | Biomerieux | Method for predicting the presence of haemostatic dysfunction in a patient sample |
US6321164B1 (en) * | 1995-06-07 | 2001-11-20 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade |
KR100489912B1 (ko) * | 1996-06-27 | 2005-09-14 | 코닌클리케 필립스 일렉트로닉스 엔.브이. | 보조정보를포함하는정보매체,판독장치및그정보매체를제조하는방법 |
RU2219596C2 (ru) | 1996-11-22 | 2003-12-20 | Конинклийке Филипс Электроникс Н.В. | Носитель информации, содержащий вспомогательную информацию, устройство считывания и способ изготовления такого носителя информации |
ATE332118T1 (de) * | 1997-03-03 | 2006-07-15 | Nir Diagnostics Inc | Vorrichtung zur bestimmung von störenden substanzen im plasma |
US6502040B2 (en) * | 1997-12-31 | 2002-12-31 | Biomerieux, Inc. | Method for presenting thrombosis and hemostasis assay data |
DE29813965U1 (de) | 1998-08-04 | 1999-12-16 | Lmb Technologie GmbH, 85445 Oberding | Vorrichtung zum Bestimmen eines Hämoglobinwerts von Blut |
WO2000046603A1 (en) * | 1999-02-04 | 2000-08-10 | Akzo Nobel N.V. | A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample |
AU2000268132A1 (en) * | 1999-09-03 | 2001-04-10 | Quantis Formulation Inc. | Method of optimizing parameter values in a process of producing a product |
US20020186363A1 (en) * | 1999-09-03 | 2002-12-12 | James Samsoondar | Method and apparatus for screening plasma for interferents in plasma from donor blood bags |
US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
DE10306024B3 (de) * | 2003-02-13 | 2004-05-06 | Siemens Ag | Multivariate, prädiktive Regelung eines Herstellungsprozesses, insbesondere eines Direktreduktionsprozesses |
RU2251095C1 (ru) * | 2004-03-16 | 2005-04-27 | Томский политехнический университет | Способ прогнозирования износостойкости твердосплавных режущих инструментов |
US7263874B2 (en) * | 2005-06-08 | 2007-09-04 | Bioscale, Inc. | Methods and apparatus for determining properties of a fluid |
US20080063628A1 (en) * | 2006-09-11 | 2008-03-13 | Davis Janet E | Methods to promote cell differentiation |
-
2009
- 2009-02-13 RU RU2010137983/28A patent/RU2503948C2/ru active
- 2009-02-13 US US12/867,635 patent/US8548935B2/en active Active
- 2009-02-13 AU AU2009213995A patent/AU2009213995B2/en active Active
- 2009-02-13 CN CN2009801053910A patent/CN101946169B/zh active Active
- 2009-02-13 EP EP09711030A patent/EP2245442A1/en active Pending
- 2009-02-13 WO PCT/FI2009/000025 patent/WO2009101242A1/en active Application Filing
- 2009-02-13 JP JP2010546371A patent/JP5602027B2/ja active Active
- 2009-02-13 CA CA2715241A patent/CA2715241C/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2009213995A1 (en) | 2009-08-20 |
AU2009213995B2 (en) | 2014-05-22 |
CA2715241C (en) | 2017-10-31 |
JP2011512593A (ja) | 2011-04-21 |
US8548935B2 (en) | 2013-10-01 |
CA2715241A1 (en) | 2009-08-20 |
CN101946169B (zh) | 2013-06-12 |
EP2245442A1 (en) | 2010-11-03 |
US20110016073A1 (en) | 2011-01-20 |
RU2010137983A (ru) | 2012-03-20 |
CN101946169A (zh) | 2011-01-12 |
WO2009101242A1 (en) | 2009-08-20 |
RU2503948C2 (ru) | 2014-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3004880B1 (en) | Calibration for multi-component assays | |
CN105229447B (zh) | 用于光度测定的校准方法 | |
Moreau et al. | Performance characteristics of the VIDAS® 25-OH Vitamin D Total assay–comparison with four immunoassays and two liquid chromatography-tandem mass spectrometry methods in a multicentric study | |
JPH0815264A (ja) | 検量関係式の再校正法及び定量試験キット | |
CN107505346B (zh) | 预测流体类别样本中特别是生物流体样本中nmr自旋系统的化学位移值的方法 | |
CN101680876A (zh) | 全血检测 | |
Jasensky et al. | Evaluation of three different point‐of‐care tests for quantitative measurement of canine C‐reactive protein | |
Hindenberg et al. | Evaluation of a novel quantitative canine species-specific point-of-care assay for C-reactive protein | |
Cui et al. | Combining Nordtest method and bootstrap resampling for measurement uncertainty estimation of hematology analytes in a medical laboratory | |
Meng et al. | Serum triglyceride measurements: the commutability of reference materials and the accuracy of results | |
CN107430123A (zh) | 用于在传感器表面上检测分析物‑配体结合的方法 | |
JP5602027B2 (ja) | 未来の性質を予測する方法 | |
JP3332167B2 (ja) | マイクロプレートリーダー | |
JP2021009135A (ja) | 情報処理装置、情報処理装置の制御方法、及びプログラム | |
Bordbar | Interpreting the deluge of omics data: new approaches offer new possibilities | |
JP2007513399A (ja) | 生化学画像の生成及びその使用方法 | |
GB2457678A (en) | Method for predicting a future property | |
Ungerer et al. | A fit-for-purpose approach to analytical sensitivity applied to a cardiac troponin assay: time to escape the ‘highly-sensitive’trap | |
JP4871761B2 (ja) | 生体サンプルの分析方法、及び自動分析装置 | |
EP4367669A2 (en) | All-electronic analysis of biochemical samples | |
Mondesert et al. | A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings | |
Bicskei et al. | Calibration of bioaffinity assays using kinetic data | |
Dimech et al. | A Proposed Approach to Estimating Uncertainty of Measurement in Serological Assays | |
Brescia et al. | Total 25-hydroxyvitamin D: comparison of methods using patient samples | |
CN112485439A (zh) | 特定蛋白质反应检测方法、蛋白质检测装置和定标方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120209 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120209 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130910 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131202 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131209 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131226 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140109 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140204 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140310 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140729 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140819 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5602027 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |